The purpose of this study was to understand the role of principle economic, sociodemographic and health status factors in determining the likelihood and volume of prescription drug use. Econometric demand regression models were developed for this purpose. Ten explanatory variables were examined: family income, coinsurance rate, age, sex, race, household head education level, size of family, health status, number of medical visits, and type of provider seen during medical visits. The economic factors (family income and coinsurance) were given special emphasis in this study.^ The National Medical Care Utilization and Expenditure Survey (NMCUES) was the data source. The sample represented the civilian, noninstitutionalized residents of the ...
This work aims to describe the determinants of healthcare demand by exploiting a range of empirical ...
Objective: Using prescription claims data, the objectives of this study were: (1) to compare the pro...
ObjectivesTo examine the socioeconomic and demographic drivers associated with polypharmacy (5–9 med...
The purpose of this study was to understand the role of principle economic, sociodemographic and hea...
Summary Prescription drugs are the third largest component of US healthcare expenditures. The 2006 M...
Given the growing importance and role of drugs in the treatment of diseases, as well as replacement ...
Prescription drugs are the third largest component of U.S. healthcare spending, and quickly growing....
Graduation date: 1980The purpose of this study was to determine the effect of population\ud size, ty...
grantor: University of TorontoThis dissertation examines the socioeconomic determinants of...
This paper examines the relationship between household income and outpatient prescribed medicines in...
Prescribing behavior of physicians affected by many factors. The present study is aimed at discoveri...
How people use health care is important knowledge for public policy and private businesses. Understa...
The thesis is an analytic and empirical investigation of factors Influencing the demand for medical ...
Abstract Objective All health care systems in the world struggle with rising costs for drugs. We sou...
The nonmedical use of prescription drugs is a widely recognized public health issue, and young adult...
This work aims to describe the determinants of healthcare demand by exploiting a range of empirical ...
Objective: Using prescription claims data, the objectives of this study were: (1) to compare the pro...
ObjectivesTo examine the socioeconomic and demographic drivers associated with polypharmacy (5–9 med...
The purpose of this study was to understand the role of principle economic, sociodemographic and hea...
Summary Prescription drugs are the third largest component of US healthcare expenditures. The 2006 M...
Given the growing importance and role of drugs in the treatment of diseases, as well as replacement ...
Prescription drugs are the third largest component of U.S. healthcare spending, and quickly growing....
Graduation date: 1980The purpose of this study was to determine the effect of population\ud size, ty...
grantor: University of TorontoThis dissertation examines the socioeconomic determinants of...
This paper examines the relationship between household income and outpatient prescribed medicines in...
Prescribing behavior of physicians affected by many factors. The present study is aimed at discoveri...
How people use health care is important knowledge for public policy and private businesses. Understa...
The thesis is an analytic and empirical investigation of factors Influencing the demand for medical ...
Abstract Objective All health care systems in the world struggle with rising costs for drugs. We sou...
The nonmedical use of prescription drugs is a widely recognized public health issue, and young adult...
This work aims to describe the determinants of healthcare demand by exploiting a range of empirical ...
Objective: Using prescription claims data, the objectives of this study were: (1) to compare the pro...
ObjectivesTo examine the socioeconomic and demographic drivers associated with polypharmacy (5–9 med...